3.4.22.43	Alopecia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17934903&form=6&db=m	Evaluation of the CTSL2 Gene as a Candidate Gene For Alopecia X in Pomeranians and Keeshonden.	causal interaction,diagnostic usage,ongoing research,therapeutic application	1,1,2,1	
3.4.22.43	Arthritis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17869649&form=6&db=m	Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,3,4,1	
3.4.22.43	Arthritis, Juvenile	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17869649&form=6&db=m	Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,3,4,1	
3.4.22.43	Arthritis, Rheumatoid	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17869649&form=6&db=m	Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,3,4,1	
3.4.22.43	Atherosclerosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20578711&form=6&db=m	Solution phase synthesis of a combinatorial library of chalcones and flavones as potent cathepsin V inhibitors.	causal interaction,therapeutic application,unassigned	4,4,0	
3.4.22.43	Autoimmune Diseases	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17869649&form=6&db=m	Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,3,4,1	
3.4.22.43	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28424560&form=6&db=m	An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.	causal interaction,diagnostic usage,therapeutic application,unassigned	1,1,1,0	
3.4.22.43	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33298139&form=6&db=m	Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,1,4,2	
3.4.22.43	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33298139&form=6&db=m	Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,1,4,2	
3.4.22.43	Carcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32910988&form=6&db=m	Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells.	causal interaction,diagnostic usage,ongoing research,unassigned	3,2,3,0